RAIA DROGASIL S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.62 BRL | +2.69% |
|
+0.67% | -12.86% |
| 03-06 | Transcript : Raia Drogasil S.A., Q4 2023 Earnings Call, Mar 06, 2024 | |
| 03-05 | Raia Drogasil S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2024 * | 39.27B 7.68B 615B | Sales 2025 * | 44.88B 8.78B 702B | Capitalization | 43.92B 8.59B 687B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.42B 277M 22.18B | Net income 2025 * | 1.8B 353M 28.23B | EV / Sales 2024 * | 1.3 x |
| Net Debt 2024 * | 7.03B 1.38B 110B | Net Debt 2025 * | 7.51B 1.47B 118B | EV / Sales 2025 * | 1.15 x |
| P/E ratio 2024 * |
30.4
x | P/E ratio 2025 * |
22.9
x | Employees | 57,700 |
| Yield 2024 * |
1.09% | Yield 2025 * |
1.83% | Free-Float | 74.06% |
More Fundamentals
* Assessed data
More news
Latest transcript on Raia Drogasil S.A.
More press releases
| 1 day | +2.69% | ||
| 1 week | +0.67% | ||
| Current month | -6.39% | ||
| 1 month | -5.74% | ||
| 3 months | -2.06% | ||
| 6 months | -2.36% | ||
| Current year | -12.86% |
1 week
24.45
25.86
1 month
24.4527.72
Current year
24.3029.87
1 year
24.3030.15
3 years
17.1430.15
5 years
12.2230.15
10 years
3.4530.15
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 30/06/13 | |
| Director of Finance/CFO | 60 | 28/04/13 | |
| Investor Relations Contact | 53 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 23/11/11 | |
| Director/Board Member | 72 | 28/04/13 | |
| Director/Board Member | 46 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.01% | 21 M€ | -11.76% | - | |
| 1.35% | 12 M€ | +15.09% | - | |
| 1.21% | 15 M€ | -3.58% | ||
| 1.19% | 32 M€ | -7.10% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 25.62 | +2.69% | 4,982,700 |
| 25/04/24 | 24.95 | +0.69% | 8,284,200 |
| 24/04/24 | 24.78 | -1.27% | 5,286,700 |
| 23/04/24 | 25.1 | -1.68% | 8,390,000 |
| 22/04/24 | 25.53 | +0.31% | 6,580,400 |
Delayed Quote Sao Paulo, April 26, 2024 at 09:07 pm
More quotes
Raia Drogasil S.A. specializes in the distribution of medicines, cosmetics and dermocosmetics, perfumery, personal care and beauty products. Net sales break down by family of products as follows:
- branded pharmaceuticals (42%);
- pharmaceutical additives (25.1%) ;
- OTC products (21.3%);
- generic pharmaceutical products (11.4%).
At the end of 2020, its products were marketed through a network of 2,299 pharmacies under the Drogasil (1,304) and Raia (995) brands in Brazil.
Sector
Drug Retailers
Calendar
06/05/2024
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
25.62
BRL
Average target price
30.93
BRL
Spread / Average Target
+20.73%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -12.86% | 8.57B | |
| +32.95% | 1.32B | |
| +6.76% | 419M | |
| +5.93% | 282M | |
| +10.56% | 224M | |
| -8.26% | 85.07M | |
| +20.94% | 59.57M |
- Stock Market
- Equities
- RADL3 Stock
